According to Jazz Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 11.55%. At the end of 2024 the company had an Operating Margin of 11.56%.
Year | Operating Margin | Change |
---|---|---|
2024 | 11.56% | 48.77% |
2023 | 7.77% | -176.28% |
2022 | -10.19% | 179.35% |
2021 | -3.65% | -131.33% |
2020 | 11.64% | -44.62% |
2019 | 21.02% | -24.95% |
2018 | 28.00% | 2.75% |
2017 | 27.25% | -23.84% |
2016 | 35.78% | 8.75% |
2015 | 32.91% | 154.65% |
2014 | 12.92% | -63.39% |
2013 | 35.30% | 16.63% |
2012 | 30.27% | -34.06% |
2011 | 45.90% | 143.37% |
2010 | 18.86% | 52.09% |
2009 | 12.40% | -105.96% |
2008 | -208.26% | -2% |
2007 | -212.51% | 22.13% |
2006 | -174.01% | -34.71% |
2005 | -266.50% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() | -129.15% | -1,218.18% | ๐ฎ๐ช Ireland |
![]() | 0.82% | -92.90% | ๐บ๐ธ USA |
![]() | 26.37% | 128.31% | ๐จ๐ญ Switzerland |
![]() | -7.76% | -167.19% | ๐ฎ๐ฑ Israel |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.